Literature DB >> 17881760

Adjuvant mitotane in adrenocortical carcinoma.

Jérôme Bertherat, Joël Coste, Xavier Bertagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17881760     DOI： 10.1056/NEJMc076267

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

Review 1.  Management of adjuvant mitotane therapy following resection of adrenal cancer.

Authors:  M Terzolo; A Ardito; B Zaggia; F Laino; A Germano; S De Francia; F Daffara; A Berruti
Journal:  Endocrine       Date:  2012-06-17       Impact factor: 3.633

2.  Adjuvant mitotane for adrenocortical cancer--a recurring controversy.

Authors:  Hui Huang; Tito Fojo
Journal:  J Clin Endocrinol Metab       Date:  2008-10       Impact factor: 5.958

Review 3.  Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.

Authors:  Irina Veytsman; Lynnette Nieman; Tito Fojo
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

4.  Emerging therapy for adrenocortical carcinoma.

Authors:  Rachel D Aufforth; Naris Nilubol
Journal:  Int J Endocr Oncol       Date:  2014

Review 5.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

6.  Therapy of adrenocortical cancer: present and future.

Authors:  Daniela F Maluf; Brás H de Oliveira; Enzo Lalli
Journal:  Am J Cancer Res       Date:  2010-12-07       Impact factor: 6.166

7.  A G-CSF-secreting adrenal carcinoma with rhabdoid-like differentiation causing leukocytosis.

Authors:  Emil Lou; Jeremy Goodwin; David N Howell; John Hicks; L Brett Caram
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

Review 8.  Novel targeted therapies in adrenocortical carcinoma.

Authors:  Bhavana Konda; Lawrence S Kirschner
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-06       Impact factor: 3.243

9.  Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.

Authors:  Tobias Else; Andrew R Williams; Aaron Sabolch; Shruti Jolly; Barbra S Miller; Gary D Hammer
Journal:  J Clin Endocrinol Metab       Date:  2013-12-03       Impact factor: 5.958

10.  Current and emerging therapeutic options in adrenocortical cancer treatment.

Authors:  Antonio Stigliano; Lidia Cerquetti; Camilla Sampaoli; Barbara Bucci; Vincenzo Toscano
Journal:  J Oncol       Date:  2012-08-14       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.